Drug combination therapy increases successful drug repositioning-Reference-Cited by-同舟云学术

Drug combination therapy increases successful drug repositioning

Published:2016-07 Issue:7 Volume:21 Page:1189-1195
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Sun Wei,Sanderson Philip E.,Zheng Wei

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference67 articles.

1. 2014 FDA drug approvals;Mullard;Nat. Rev. Drug Discov.,2015

2. 2014 prescription medications in the United States: tremendous growth, specialty/orphan drug expansion, and dispensed prescriptions continue to increase;Lindsley;ACS Chem. Neurosci.,2015

3. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction;Boolell;Int. J. Impot. Res.,1996

4. Inhibition of angiogenesis by the antifungal drug itraconazole;Chong;ACS Chem. Biol.,2007

5. Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer;Rudin;J. Thorac. Oncol.,2013

Cited by 316 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target repositioning using multi-layer networks and machine learning: The case of prostate cancer;Computational and Structural Biotechnology Journal;2024-12

2. Unlocking the potential of signature-based drug repurposing for anticancer drug discovery;Archives of Biochemistry and Biophysics;2024-11

3. Emerging pharmacological approaches for Huntington's disease;European Journal of Pharmacology;2024-10

4. Fabrication of micro spherulitic particles of carbamazepine-hesperetin cocrystal via QESD with enhanced manufacturability and dissolution;Particuology;2024-10

5. Non-Negative Matrix Tri-Factorization for Representation Learning in Multi-Omics Datasets with Applications to Drug Repurposing and Selection;International Journal of Molecular Sciences;2024-09-04